Skip to content
Search

Latest Stories

RPS proposes transition to Royal College, seeks feedback from pharmacy community

RPS proposes transition to Royal College, seeks feedback from pharmacy community

The proposed changes will need approval from RPS members through a vote, which is anticipated in early 2025

The Royal Pharmaceutical Society (RPS), the professional leadership body for pharmacists and pharmaceutical scientists in Great Britain, has today announced its proposal to transition into a royal college, becoming the Royal College of Pharmacy.

This move follows an 18-month independent review of the RPS constitution and governance and is aimed at strengthening the RPS's leadership role to better support its members.


The organisation proposes to enhance its core activities in education, assessment, credentialing, and setting professional standards, ultimately benefiting patients and the public.

Under the proposed new structure, the RPS’s knowledge business, Pharmaceutical Press, would become a wholly owned subsidiary called Pharmaceutical Press Ltd, accountable to the charitable body of the Royal College of Pharmacy.

RPS President Professor Claire Anderson said:  "Pharmacy is changing rapidly and the expectations placed upon pharmacists and the wider pharmacy team will have profound repercussions in terms of delivering patient care.

“It’s time for pharmacy to take its place alongside other health and medical professional leadership bodies and for RPS to become the Royal College of Pharmacy.”

She added that the transformation to a Royal College will reinforce the RPS’s mission and enhance its capacity.

“Becoming a Royal College is a natural progression, reinforcing our commitment to our members and enhancing our capacity to serve patients and the public.

“It will empower us to better advocate for pharmacy and deliver our mission and vision; ensuring that we are always at the forefront of the safe and effective use of medicines.”

RPS plans to hold a series of engagement events across Great Britain starting in October and running over two months to provide details about the proposed changes and gather feedback.

The proposed changes will require approval from RPS members through a vote before they can be submitted to the Privy Council for amendments to the organisation's current Royal Charter and to charity regulators.

The vote is anticipated to take place in early 2025, with a two-thirds majority needed from voting members to move the changes forward.

RPS Chief Executive Paul Bennett emphasised that the proposed change in status reflects the organisation's commitment to upholding the highest standards of professional leadership and patient care.

“It will enable us to be more agile, collaborative and influential across healthcare. As a Royal College, we will have a stronger platform to advance the profession, push for the best possible outcomes for patients and support our members through a rapidly evolving environment,” he said.

The RPS is inviting feedback from the pharmacy community on these proposals and encourages everyone to participate in shaping the organisation’s future.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less